2 Biotech Cos. Tap Follow-On Market For Nearly $500M
Avexis Inc., a biotech company developing treatments for rare genetic diseases, on Tuesday priced a $235 million follow-on offering to fund research and manufacturing activities, while Loxo Oncology Inc. closed a...To view the full article, register now.
Already a subscriber? Click here to view full article